Skip to main content
SpringerLink
Log in

Venous Thromboembolism

  • Living reference work entry
  • Latest version View entry history
  • First Online:
Family Medicine

  • 19 Accesses

Abstract

Deep vein thrombosis (DVT) and pulmonary embolism (PE) represent two of the most significant manifestations of venous thromboembolism (VTE). Only myocardial infarction and stroke are more prevalent in terms of life-threatening cardiovascular disease (Stein PD, Matta F, Clin Chest Med. 31:611–628, 2010). While diagnosis can be challenging due to the wide spectrum of presentation, it is essential to maintain vigilance for these conditions in order to reduce potentially life-threatening and long-term complications. Evaluating the patient’s history, signs and symptoms, risk factors, the use of validated clinical prediction rules, and appropriate diagnostic studies are essential for prompt detection. Once diagnosed, multiple effective treatment options, including well-tolerated oral anticoagulants, are available for short- and long-term therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Stein PD, Matta F. Epidemiology and incidence: the scope of the problem and risk factors for development of venous thromboembolism. Clin Chest Med. 2010;31:611–28.

    Article  PubMed  Google Scholar 

  2. Tritschler T, Kraaijpoel N, Le Gal G, Wells PS. Venous thromboembolism: advances in diagnosis and treatment. JAMA. 2018;320(15):1583–94.

    Article  PubMed  Google Scholar 

  3. Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol. 2008;143(2):180.

    Article  PubMed  Google Scholar 

  4. Folsom AR, Lutsey PL, Astor BC, et al. C-reactive protein and venous thromboembolism: a prospective investigation in the ARIC cohort. Thromb Haemost. 2009;102:615–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Joffe HV, Kucher N, Tapson VF, et al. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation. 2004;110:1605–11.

    Article  PubMed  Google Scholar 

  6. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008;28:370–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44(2):62–9.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med. 2017;377:1177–87.

    Article  PubMed  Google Scholar 

  9. Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41:3–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Centers for Disease Control and Prevention. Venous thromboembolism (blood clots). Data and statistics. February 7, 2020. http://www.cdc.gov/ncbddd/dvt/data.html. Accessed 20 Mar 2020.

  11. Piccioli A, Falanga A, Baccaglini U, et al. Cancer and venous thromboembolism. Semin Thromb Hemost. 2006;32:694–9.

    Article  PubMed  Google Scholar 

  12. Wilbur J, Shian B. Diagnosis of deep venous thrombosis and pulmonary embolism. Am Fam Physician. 2012;86:913–9.

    PubMed  Google Scholar 

  13. Wells P, Anderson D. The diagnosis and treatment of venous thromboembolism. Hematol Am Soc Hematol Educ Program. 2013;2013:457–63.

    Article  Google Scholar 

  14. Wells PS, Ihaddadene R, Reilly A, Forgie MA. Diagnosis of venous thromboembolism: 20 years of progress. Ann Intern Med. 2018;168:131–40.

    Article  PubMed  Google Scholar 

  15. Lim W, LeGal G, Bates SM, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. Blood Adv. 2018;2(22):3226–56.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Wells PS, Anderson DR, Rodgers M, et al. Derivation of a simple clinical model to categorize patients’ probability of pulmonary embolism: increasing the model’s utility with simpliRED D-dimer. Thromb Haemost. 2000;83:416–20.

    Article  CAS  PubMed  Google Scholar 

  17. Ten Cate-Hoek AJ, Prins MH. Management studies using a combination of D-dimer test result and clinical probability to rule out venous thromboembolism: a systematic review. J Thromb Haemost. 2005;3:2465–70.

    Article  PubMed  Google Scholar 

  18. Kline JA. Diagnosis and exclusion of pulmonary embolism. Thromb Res. 2018;163:207–20.

    Article  CAS  PubMed  Google Scholar 

  19. Singh B, Mommer SK, Erwin PJ, et al. Pulmonary embolism rule-out criteria (PERC) in pulmonary embolism–revisited: a systematic review and meta-analysis. Emerg Med J. 2013;30(9):701–6.

    Article  PubMed  Google Scholar 

  20. van Es N, Kraaijpoel N, Klok FA, et al. The original and simplified Wells rules and age-adjusted D-dimer testing to rule out pulmonary embolism: an individual patient data meta-analysis. J Thromb Haemost. 2017;15:678–84.

    Article  PubMed  Google Scholar 

  21. Righini M, Van Es J, Den Exter PL, et al. Age-adjusted d-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014;311(11):1117–24.

    Article  CAS  PubMed  Google Scholar 

  22. Stein PD, Fowler SE, Goodman LR, PIOPED II Investigators, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354:2317–27.

    Article  CAS  PubMed  Google Scholar 

  23. Remy-Jardin M, Pistolesi M, Goodman LR, et al. Management of suspected acute pulmonary embolism in the era of CT angiography: a statement from the Fleischner society. Radiology. 2007;245:315–29.

    Article  Google Scholar 

  24. Bajc M, Schümichen C, Grüning T, et al. EANM guideline for ventilation/perfusion single photon emission computed tomography (SPECT) for diagnosis of pulmonary embolism and beyond. Eur J Nucl Med Mol Imaging. 2019;46(12):2429–2451.

    Google Scholar 

  25. Phillips JJ, Straiton J, Staff RT. Planar and SPECT ventilation/perfusion imaging and computed tomography for the diagnosis of pulmonary embolism: a systematic review and meta-analysis of the literature, and cost and dose comparison. Eur J Radiol. 2015;84(7):1392–400.

    Article  CAS  PubMed  Google Scholar 

  26. van Beek EJ, Brouwerst EM, Song B, et al. Clinical validity of a normal pulmonary angiogram in patients with suspected pulmonary embolism – a critical review. Clin Radiol. 2001;56(10):838–42.

    Article  PubMed  Google Scholar 

  27. Stein PD, Chenevert TL, Fowler SE, et al. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med. 2010;152(7):434. W143.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline. Chest. 2016;149:315–52.

    Article  PubMed  Google Scholar 

  29. Jeff MR, McMurtry MS, Archer SL, et al. Management of massive and submissive pulmonary embolism, Iliofemoral deep vein thrombosis, chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123:1788–830.

    Article  Google Scholar 

  30. Watson L, Broderick C, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 2016;11:CD002783.

    Google Scholar 

  31. Wilbur J, Shian B. Deep venous thrombosis and pulmonary embolism: current therapy. Am Fam Physician. 2017;95(5):295–302.

    PubMed  Google Scholar 

  32. Büller HR, Davidson BL, Decousus H, Matisse Investigators, et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med. 2004;140(11):867–73.

    Article  PubMed  Google Scholar 

  33. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41:543–603.

    Article  Google Scholar 

  34. Raschke RA, Reilly BM, Guidry JR, et al. The weight-based heparin dosing nomogram compared with a “standard care” nomogram. A randomized controlled trial. Ann Intern Med. 1993;119(9):874.

    Article  CAS  PubMed  Google Scholar 

  35. Bauersachs R, Berkowitz SD, Brenner B, EINSTEIN Investigators, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363(26):2499–510.

    Article  CAS  PubMed  Google Scholar 

  36. Agnelli G, Buller HR, Cohen A, AMPLIFY Investigators, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369(9):799.

    Article  CAS  PubMed  Google Scholar 

  37. Witt DM, Nieuwlaat R, Clark NP, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018;2(22):3257–91.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Raskob GE, van Es N, Verhamme P, Hokusai VTE Cancer Investigators, et al. Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med. 2018;378(7):615–24.

    Article  CAS  PubMed  Google Scholar 

  39. Young AM, Marshall A, Thirlwall J, et al. Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D). J Clin Oncol. 2018;36:2017–23.

    Article  CAS  PubMed  Google Scholar 

  40. Agnelli G, Becattini C, Meyer G, et al. Apixaban for the treatment of venous thromboembolism associated with Cancer. N Engl J Med. 2020; https://doi.org/10.1056/NEJMoa1915103.

  41. Andras A, Sala Tenna A, Crawford F. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev. 2012;10:CD002001.

    PubMed  Google Scholar 

  42. Schulman S, Kearon C, Kakkar AK, RE-COVER Study Group, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009;361(24):2342–52.

    Article  CAS  PubMed  Google Scholar 

  43. Kakkos SK, Kirkilesis GI, Tsolakis IA. Efficacy & safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, & edoxaban in the treatment and secondary prevention of venous thromboembolism: systemic review & meta-analysis. Eur J Vasc Endovasc Surg. 2014;48(5):565–75.

    Article  CAS  PubMed  Google Scholar 

  44. Geldhof V, Vandenbriele C, Verhamme P, et al. Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulants. Thromb J. 2014;12:21.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  45. Prandoni P, Noventa F, Milan M. Aspirin & recurrent venous thromboembolism. Phlebology. 2013;28(1):99–104.

    Article  PubMed  Google Scholar 

  46. Cosmi B. Management of superficial vein thrombosis. J Thromb Haemost. 2015;13(7):1175–83.

    Article  CAS  PubMed  Google Scholar 

  47. Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev. 2018;(2):CD004982. https://doi.org/10.1002/14651858.CD004982.pub6.

  48. Litzendorf ME, Satiani B. Superficial venous thrombosis: disease progression and evolving treatment approaches. Vasc Health Risk Manag. 2011;7:569.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Decousus H, Quéré I, Presles E, POST Study Group, et al. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. Ann Intern Med. 2010;152(4):218.

    Article  PubMed  Google Scholar 

  50. Decousus H, Prandoni P, Mismetti P, et al. Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med. 2010;363(13):1222.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Methodist Health System Family Medicine Residency, Dallas, TX, USA

    Lawrence Gibbs

  2. Family Medicine Clinic, Hill AFB, UT, USA

    Josiah Moulton

  3. Family Medicine Clinic, Barksdale AFB, LA, USA

    Vincent Tichenor

Authors
  1. Lawrence Gibbs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Josiah Moulton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vincent Tichenor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lawrence Gibbs .

Editor information

Editors and Affiliations

  1. Department of Family Medicine, University of Nebraska, Omaha, NE, USA

    Paul Paulman

  2. Department of Family and Community Medicine, Eastern Virginia Medical School, Norfolk, VA, USA

    Robert B. Taylor

  3. Department of Family Medicine, University of Nebraska Medical Center, Omaha, NE, USA

    Audrey A. Paulman

  4. Department of Family Medicine, Creighton University, Omaha, NE, USA

    Laeth S. Nasir

Rights and permissions

Reprints and permissions

Copyright information

© 2021 This is a U.S. Government work and not under copyright protection in the U.S.; foreign copyright protection may apply

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Gibbs, L., Moulton, J., Tichenor, V. (2021). Venous Thromboembolism. In: Paulman, P., Taylor, R.B., Paulman, A.A., Nasir, L.S. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0779-3_88-3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0779-3_88-3

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-0779-3

  • Online ISBN: 978-1-4939-0779-3

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Venous Thromboembolism
    Published:
    06 March 2021

    DOI: https://doi.org/10.1007/978-1-4939-0779-3_88-3

  2. Venous Thromboembolism
    Published:
    24 August 2020

    DOI: https://doi.org/10.1007/978-1-4939-0779-3_88-2

  3. Original

    Venous Thromboembolism
    Published:
    05 August 2015

    DOI: https://doi.org/10.1007/978-1-4939-0779-3_88-1

Search

Navigation